Literature DB >> 15178940

The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy.

Jovanka Ostojic1, Christina Elfgren, Ulla Passant, Karin Nilsson, Lars Gustafson, Lars Lannfelt, Susanne Froelich Fabre.   

Abstract

Frontotemporal dementia (FTD) and Alzheimer's disease (AD) are two frequent causes of dementia that share both clinical and neuropathological features. Common to both disorders are the neurofibrillary tangles consisting of aggregations of hyperphosphorylated tau protein. Recently, a number of different pathogenic mutations in the tau gene have been identified in families with FTD and parkinsonism linked to chromosome 17 (FTDP-17). In the present study, a Swedish family with presenile degenerative dementia with bitemporal atrophy was screened for mutations in the tau gene. As a result, the R406W mutation in exon 13 was identified in all affected cases. This mutation has previously been reported in two different FTDP-17 families of Dutch and Midwestern American origin. Common features to these two kindreds and our family are the late age at onset and long duration of the disease. Our pedigree as well as the American one show early memory impairment and pronounced temporal lobar atrophy similar to AD, while the Dutch cases show more FTD features. This further illustrates the large clinical variability among cases with tau mutations and stresses the importance of genetic classification in addition to the traditional clinical classification of neurodegenerative disorders. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178940     DOI: 10.1159/000077158

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  14 in total

1.  Familial frontotemporal dementia associated with the novel MAPT mutation T427M.

Authors:  Giorgio Giaccone; Giacomina Rossi; Laura Farina; Gabriella Marcon; Giuseppe Di Fede; Marcella Catania; Michela Morbin; Leonardo Sacco; Orso Bugiani; Fabrizio Tagliavini
Journal:  J Neurol       Date:  2005-06-06       Impact factor: 4.849

Review 2.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 3.  The genetics of Alzheimer disease.

Authors:  Rudolph E Tanzi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

4.  C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.

Authors:  Matthew Harms; Bruno A Benitez; Nigel Cairns; Breanna Cooper; Paul Cooper; Kevin Mayo; David Carrell; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Richard Mayeux; Sumitra Chakraverty; Alison M Goate; Carlos Cruchaga
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

Review 5.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

6.  The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.

Authors:  Anne Gauthier-Kemper; Carina Weissmann; Nataliya Golovyashkina; Zsofia Sebö-Lemke; Gerard Drewes; Volker Gerke; Jürgen J Heinisch; Roland Brandt
Journal:  J Cell Biol       Date:  2011-02-21       Impact factor: 10.539

7.  Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation.

Authors:  Takeshi Ikeuchi; Toru Imamura; Yasuhiro Kawase; Yoshimi Kitade; Miyuki Tsuchiya; Takayoshi Tokutake; Kensaku Kasuga; Ryuji Yajima; Tamao Tsukie; Akinori Miyashita; Morihiro Sugishita; Ryozo Kuwano; Masatoyo Nishizawa
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-09-20

8.  Piericidin A aggravates Tau pathology in P301S transgenic mice.

Authors:  Matthias Höllerhage; Roman Deck; Anderson De Andrade; Gesine Respondek; Hong Xu; Thomas W Rösler; Mohamed Salama; Thomas Carlsson; Elizabeth S Yamada; Seham A Gad El Hak; Michel Goedert; Wolfgang H Oertel; Günter U Höglinger
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

9.  18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.

Authors:  Ruben Smith; Andreas Puschmann; Michael Schöll; Tomas Ohlsson; John van Swieten; Michael Honer; Elisabet Englund; Oskar Hansson
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

10.  Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation.

Authors:  Regina M Carney; Martin A Kohli; Brian W Kunkle; Adam C Naj; John R Gilbert; Stephan Züchner; Margaret A Pericak-Vance
Journal:  Alzheimers Dement       Date:  2013-05-30       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.